Nanordica Medical develops nanotechnology-based antibacterial wound care products for people and animals.
Founded in 2019, Nanordica Medical develops antibacterial wound dressings and related products for human and veterinary care. Its solutions target infected wounds, diabetic foot ulcers, burns, surgical wounds and traumatic injuries. The company is based in Tallinn, Estonia, and was co-founded by Olesja Bondarenko. In May 2026, it raised EUR 1.6 million led by 2C Ventures, with participation from Health Founders, Estonian Business Angels Network, Specialist VC, Superangel and Amalfi, to complete a clinical trial, obtain CE marking and prepare Premotiv's European launch.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign inWork at Nanordica Medical OU? This is my company